H1N1 Report Boosts Biopharmaceutical Sector: CBIS, ACAD, ACCP - sourced PicksThatMove.com
Cannabis Science Inc - ACADIA Pharmaceuticals Inc - Access Pharmaceuticals
Calgary, AB 7/24/2009 07:28 PM GMT (TransWorldNews)
Calgary, Alberta - PicksThatMove.com opines promising trading opportunities with likely potential for gain. The companies we follow have favourable revenue models for business development at upward cycles. To view more of our profiled stocks, please visit us at PicksThatMove.com
H1N1 Report Boosts Biopharmaceutical Sector: CBIS, ACAD, ACCP
The hot stock information of the day includes:
Cannabis Science, Inc. (OTC:CBIS) catapulted 53.58% up to $0.450 with 690,240 shares trading actively in mid-afternoon on news that research published by CNN today indicates the current H1N1 influenza virus has disturbing similarities to the 1918 pandemic and pushed the company to release its anti-inflammatory cannabis drug. The Wall Street Journal published an article yesterday on the booming medicinal marijuana industry mentioning Cannabis Science, Inc. The company reports on its website that all influenza strains that elicit an excessive inflammatory immune response are targeted with Cannabis Science formulations. Based in Palm Springs, California, Cannabis Science, Inc. is at the forefront of medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shot up 29.23% to $3.38 with a volume of 2,353,337on no news. ACADIA Pharmaceuticals, Inc., is a biopharmaceutical company that discovers, develops, and commercializes small molecule drugs for the treatment of central nervous system disorders.
Access Pharmaceuticals, Inc. (OTC:ACCP) gained 18.10% to $3.72 with 266,887 shares moving this afternoon on no news. Access Pharmaceuticals Inc., is a biopharmaceutical company engaged in the development of novel therapeutics for the treatment of cancer and supportive care of cancer patients.
To be kept up to date on all of our hot stock information join us at Picks That Move.
About PicksThatMove.com:
PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies. PicksThatMove.com is not a registered investment advisor or broker-dealer. PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value. We recommend Due Diligence before investing in any stock.